Pazeo FDA Approval History
FDA Approved: Yes (First approved January 30, 2015)
Brand name: Pazeo
Generic name: olopatadine hydrochloride
Dosage form: Ophthalmic Solution
Company: Alcon Laboratories, Inc.
Treatment for: Conjunctivitis, Allergic
Pazeo (olopatadine hydrochloride) is a mast cell stabilizer for the treatment of ocular itching associated with allergic conjunctivitis.
Development timeline for Pazeo
| Date | Article |
|---|---|
| Feb 2, 2015 | Approval Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
